192 related articles for article (PubMed ID: 33760168)
1. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
Liu Y; Fu X; Wang X; Liu Y; Song X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
[TBL] [Abstract][Full Text] [Related]
2. Potential role of lncRNA HULC/miR‑128‑3p/RAC1 axis in the inflammatory response during LPS‑induced sepsis in HMEC‑1 cells.
Yang W; Luo X; Liu Y; Xiong J; Xia H; Liu Y
Mol Med Rep; 2020 Dec; 22(6):5095-5104. PubMed ID: 33174038
[TBL] [Abstract][Full Text] [Related]
3. lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F3.
Yao J; Wang C; Dong X; Zhang Y; Li Y; Zhou H; Zhang L
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368861
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
Xu H; Sun X; Huang Y; Si Q; Li M
Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
[TBL] [Abstract][Full Text] [Related]
5. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
Sun M; Chen Y; Liu X; Cui Y
Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
[TBL] [Abstract][Full Text] [Related]
6. FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.
Yang X; Du H; Bian W; Li Q; Sun H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760158
[TBL] [Abstract][Full Text] [Related]
7. Long non coding RNA OIP5‑AS1 promotes metastasis of breast cancer via miR‑340‑5p/ZEB2 axis.
Meng L; Yue X; Zhou D; Li H
Oncol Rep; 2020 Oct; 44(4):1662-1670. PubMed ID: 32945479
[TBL] [Abstract][Full Text] [Related]
8. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA MCM3AP‑AS1 drives ovarian cancer progression via the microRNA‑143‑3p/TAK1 axis.
Wen J; Han S; Cui M; Wang Y
Oncol Rep; 2020 Oct; 44(4):1375-1384. PubMed ID: 32945454
[TBL] [Abstract][Full Text] [Related]
12. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
Xu Y; Zhang Q; Miao C; Dongol S; Li Y; Jin C; Dong R; Li Y; Yang X; Kong B
Cancer Med; 2019 Jan; 8(1):351-362. PubMed ID: 30565428
[TBL] [Abstract][Full Text] [Related]
13. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR‑1321 and regulating tight junction protein 3 expression.
Luo M; Zhang L; Yang H; Luo K; Qing C
Mol Med Rep; 2020 Oct; 22(4):3429-3439. PubMed ID: 32945443
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-488 inhibits ovarian cancer cell metastasis through regulating CCNG1 and p53 expression.
Guo JY; Wang XQ; Sun LF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2902-2910. PubMed ID: 32271408
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
19. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
20. LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
J Cell Physiol; 2020 Apr; 235(4):3939-3949. PubMed ID: 31595977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]